Thomas Weisel Starts Obagi Medical (OMPI) at Market Weight
OMPI Hot Sheet
Rating Summary:2 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
Thomas Weisel starts Obagi Medical (Nasdaq: OMPI) at Market Weight with a $7 price target.
Obagi Medical Products, Inc., a specialty pharmaceutical company, develops and markets skincare products in the United States and internationally.
Obagi Medical Products, Inc., a specialty pharmaceutical company, develops and markets skincare products in the United States and internationally.
You May Also Be Interested In
- UPDATE: William Blair Starts EPIQ Systems (EPIQ) at Outperform; Broad Suite of Solutions in Electronic Discovery Sector
- Oppenheimer Starts LivePerson (LPSN) at Outperform
- Wunderlich Securities Starts Anixter International (AXE) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Thomas Weisel Partners GroupSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
